Ligand validation:8IR5

HTG: heptyl 1-thio-beta-D-glucopyranoside

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8IR5_HTG_B_625	77%	43%	0.094	0.933	1.04	1.22	2	3	0	0	100%	1
8IR5_HTG_b_625	63%	36%	0.108	0.903	1.01	1.61	2	5	0	0	100%	1
8IR5_HTG_B_622	30%	34%	0.178	0.839	1.16	1.52	2	5	0	0	100%	1
8IR5_HTG_c_522	18%	38%	0.266	0.852	0.97	1.54	2	2	0	0	100%	1
8IR5_HTG_b_622	17%	26%	0.203	0.781	1.2	1.94	2	7	0	0	100%	1
8IR5_HTG_B_623	13%	43%	0.246	0.783	0.79	1.47	1	2	0	0	100%	1
8IR5_HTG_C_520	12%	43%	0.312	0.842	0.89	1.33	1	2	0	0	100%	1
8IR5_HTG_V_202	6%	65%	0.407	0.916	0.23	1.08	-	1	0	0	58%	0.5789
8IR5_HTG_d_409	5%	36%	0.299	0.741	0.98	1.59	1	1	0	0	84%	0.8421
8IR5_HTG_D_410	4%	36%	0.287	0.674	1.08	1.5	2	1	0	0	84%	0.8421
8IR5_HTG_b_623	1%	30%	0.455	0.597	1.05	1.87	1	2	0	0	100%	1
5V2C_HTG_O_303	94%	35%	0.072	0.972	1.58	1.07	2	2	0	0	100%	1
3WU2_HTG_O_303	89%	38%	0.092	0.971	1.17	1.32	2	1	0	0	100%	1
8IR7_HTG_b_625	81%	38%	0.086	0.939	0.97	1.5	2	3	0	0	100%	1
8IR6_HTG_b_625	81%	37%	0.088	0.941	1.07	1.48	2	4	0	0	100%	1
8IRA_HTG_B_625	81%	46%	0.097	0.95	0.97	1.12	2	2	0	0	100%	1
8IR9_HTG_B_623	81%	46%	0.098	0.95	0.99	1.13	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.